Mass H, Gwirtz P A
Department of Physiology, Texas College of Osteopathic Medicine, Forth Worth 76107.
Med Sci Sports Exerc. 1987 Oct;19(5):443-50.
This study was designed to examine the contribution of beta 1- and beta 2-adrenergic receptors in modulating coronary blood flow and cardiac function in exercising dogs. Dogs were chronically instrumented to measure left circumflex flow velocity (CFV), heart rate, regional left ventricular function [systolic shortening, (%S) and maximum velocity of shortening (dL/dt(s)max)], and global left ventricular function [left ventricular pressure (LVP and dP/dtmax)]. Exercise significantly increased LVP (31 +/- 4%), dP/dtmax (130 +/- 17%), heart rate (116 +/- 20%), %S (28 +/- 6%), dL/dt(s)max (89 +/- 23%), and CFV (91 +/- 25%). Regional injection of the non-selective beta-blocker propranolol (1.0 mg) into the circumflex artery during exercise was associated with decreases in LVP (-8 +/- 3%), dP/dtmax (-17 +/- 3%), %S (-15 +/- 4), dL/dt(s)max (-13 +/- 4%), and CFV (-22 +/- 4%). Selective beta 1-receptor blockade with atenolol (1.0 mg, i.c.) was associated with similar decreases in LVP (-7 +/- 3%), dP/dtmax (-33 +/- 4%), %S (-12 +/- 3%), dL/dt(s)max (-17 +/- 2%), and CFV (-18 +/- 3%) during exercise. In contrast, selective beta 2-receptor blockade with ICI 118551 (250 micrograms, i.c.) produced significant decreases in only CFV (-11 +/- 2%) during exercise. Thus, the data suggest that the reductions in myocardial contractile function and flow after regional beta-blockade are primarily due to a decrease in myocardial beta 1-receptor stimulation. In addition, there apparently is a small involvement of either coronary vascular or pre-synaptic beta 2-receptors in mediating the coronary vascular flow response during exercise.
本研究旨在探讨β1和β2肾上腺素能受体在调节运动犬冠状动脉血流和心脏功能中的作用。对犬进行长期仪器植入,以测量左旋支血流速度(CFV)、心率、局部左心室功能[收缩期缩短率(%S)和最大缩短速度(dL/dt(s)max)]以及整体左心室功能[左心室压力(LVP和dP/dtmax)]。运动显著增加了LVP(31±4%)、dP/dtmax(130±17%)、心率(116±20%)、%S(28±6%)、dL/dt(s)max(89±23%)和CFV(91±25%)。运动期间,在左旋支动脉局部注射非选择性β受体阻滞剂普萘洛尔(1.0mg),可使LVP降低(-8±3%)、dP/dtmax降低(-17±3%)、%S降低(-15±4%)、dL/dt(s)max降低(-13±4%)和CFV降低(-22±4%)。运动期间,静脉注射阿替洛尔(1.0mg,i.c.)进行选择性β1受体阻断,可使LVP降低(-7±3%)、dP/dtmax降低(-33±4%)、%S降低(-12±3%)、dL/dt(s)max降低(-17±2%)和CFV降低(-18±3%)。相比之下,静脉注射ICI 118551(250μg,i.c.)进行选择性β2受体阻断,仅在运动期间使CFV显著降低(-11±2%)。因此,数据表明,局部β受体阻断后心肌收缩功能和血流的降低主要是由于心肌β1受体刺激的减少。此外,在运动期间介导冠状动脉血流反应的过程中,冠状动脉血管或突触前β2受体显然仅有少量参与。